VIRSCIO

Overview

Virscio provides translational preclinical research supported by advanced imaging, histopathology, molecular analysis, and African green monkey (NHP) models.

Services

• NHP research services: in vivo primate efficacy and safety, pharmacokinetics, pharmacodynamics, and delivery studies.
• Histopathology services: digital histopathology integrated with in vivo research.
• Molecular biology services: molecular analysis supporting translational models.
• Strategy and execution: preclinical strategy, protocol design, in-life study execution, sample processing, data analysis, study reporting, and defining the regulatory pathway, from IND-enabling safety studies onward.

Compliance

Virscio states that its animal program consistently meets AAALAC and OLAW standards, aligned with USDA and European animal welfare guidance. The company operates under FDA good laboratory practice (GLP) and supports studies intended for regulatory submission under OECD GLP.

Therapeutic focus

Capabilities are described across central nervous system, ophthalmology, cardiometabolic, gene and cell therapies, protein and RNA therapies, and aging biology.